Evidence map›Paper›PMID 24789183›Full record

ArticleJournal of clinical microbiology2014

Lowenstein-Jensen selective medium for reducing contamination in Mycobacterium tuberculosis culture.

Kennedy Kassaza, Patrick Orikiriza, Augusto Llosa, Joel Bazira, Dan Nyehangane, Anne-Laure Page, Yap Boum

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Molecular Characterization of theAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Advances in TB testing.Advances in clinical chemistry · 2023
    Article
  7. Article
  8. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.Journal of clinical tuberculosis and other mycobacterial diseases · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Comparison ofJournal of medical science and clinical research · 2017
    Article
  16. Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2016
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kennedy KassazaEpicentre Mbarara, Mbarara, Uganda epi-ug-labmanager@epicentre.msf.org yap.boum@epicentre.msf.org.
Patrick OrikirizaEpicentre Mbarara, Mbarara, Uganda.
Augusto LlosaEpicentre, Paris, France.
Joel BaziraMbarara University of Science and Technology, Mbarara, Uganda.
Dan NyehanganeEpicentre Mbarara, Mbarara, Uganda.
Anne-Laure PageEpicentre, Paris, France.
Yap BoumEpicentre Mbarara, Mbarara, Uganda Mbarara University of Science and Technology, Mbarara, Uganda epi-ug-labmanager@epicentre.msf.org yap.boum@epicentre.msf.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We compared Mycobacterium tuberculosis sputum culture recovery and contamination rates between Lowenstein-Jensen medium (LJ) containing the following decontaminants and LJ alone: (i) PANTA (n = 299), (ii) Selectatab-MB (n = 299), and (iii) penicillin G (n = 234). The contamination rate for LJ alone was approximately 31%, versus 5.0% for PANTA-containing, 2% for Selectatab-containing, and 9% for penicillin-containing media (P < 0.001). M. tuberculosis isolation rates were 9.8%, 17%, 18%, and 12% for standard LJ, PANTA, Selectatab, and penicillin cultures, respectively.

Indexed as

Bacteriological TechniquesCulture MediaHumansMycobacterium tuberculosisSelection, GeneticSputumTuberculosis, PulmonaryCulture Media

Identifiers

PMID24789183
PMCPMC4097697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.